Microbiota dysbiosis after high-dose melphalan and autologous hematopoietic cell transplantation in multiple myeloma

被引：1
|
作者：
Malard, Florent [1 ,2 ]
Battipaglia, Giorgia [1 ,2 ]
Gaugler, Beatrice [2 ]
Siblany, Lama [2 ]
van de Wyngaert, Zoe [1 ,2 ]
Bonnin, Agnes [1 ,2 ]
Dulery, Remy [1 ,2 ]
Banet, Anne [1 ,2 ]
Stocker, Nicolas [1 ,2 ]
Ricard, Laure [1 ,2 ]
Brissot, Eolia [1 ,2 ]
Mohty, Mohamad [1 ,2 ]
机构：
[1] Sorbonne Univ, Hop St Antoine, Serv Hematol Clin & Therapie Cellulaire, APHP, Paris, France
[2] INSERM, Ctr Rech St Antoine CRSA, F-75012 Paris, France
来源：
BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / 11期
关键词：
D O I：
10.1038/s41409-023-02078-1
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1275 / 1278
页数：4
相关论文
共 50 条
  • [1] Microbiota dysbiosis after high-dose melphalan and autologous hematopoietic cell transplantation in multiple myeloma
    Florent Malard
    Giorgia Battipaglia
    Béatrice Gaugler
    Lama Siblany
    Zoe van de Wyngaert
    Agnes Bonnin
    Rémy Duléry
    Anne Banet
    Nicolas Stocker
    Laure Ricard
    Eolia Brissot
    Mohamad Mohty
    Bone Marrow Transplantation, 2023, 58 : 1275 - 1278
  • [2] Busulfan, Melphalan, and Bortezomib versus High-Dose Melphalan as a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
    Rodriguez, Tulio E.
    Hari, Parameswaran
    Stiff, Patrick J.
    Smith, Scott E.
    Sterrenberg, Danielle
    Vesole, David H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (08) : 1391 - 1396
  • [3] Impact of Obesity in Patients with Multiple Myeloma Receiving High-Dose Melphalan Followed By Autologous Hematopoietic Cell Transplantation
    Frimpong, Justina Ofori
    Tombleson, Rebecca
    Alsina, Melissa
    Shapiro, Jamie
    Kim, Jongphil
    Yue, Binglin
    Perkins, Janelle
    Nishihori, Taiga
    BLOOD, 2016, 128 (22)
  • [4] Arsenic trioxide with ascorbic acid and high-dose melphalan for autologous hematopoietic stem cell transplantation for multiple myeloma
    Qazilbash, M. H.
    Jindani, S.
    Gul, Z.
    Saliba, R.
    Hosing, C.
    Mendoza, F.
    Qureshi, S. P.
    Weber, D. M.
    Wang, M.
    Flosser, T.
    Couriel, D. P.
    Kebriaei, P.
    Popat, U.
    Alousi, A. M.
    De Lima, M.
    Champlin, R. E.
    Giralt, S. A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 9 - 10
  • [5] Pegfilgrastim versus filgrastim to accelerate hematopoietic recovery after high-dose melphalan and autologous hematopoietic stem cell transplantation (ASCT) for multiple myeloma
    Olin, RL
    Luger, SM
    Porter, DL
    Schuster, SJ
    Tsai, D
    Nasta, S
    Perl, A
    Loren, AW
    Goldstein, S
    Mangan, P
    Sherry, V
    Cunningham, K
    Sachs, B
    Hummel, K
    Stadtmauer, EA
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 87 - 87
  • [6] "Secondary MGUS" After High-Dose Melphalan and Autologous Hematopoietic Progenitor Cell Transplantation In Multiple Myeloma: A Matter of Undetermined Significance.
    Manson, Greg V.
    Campagnaro, Erica L.
    Fu, Pingfu
    Sommers, Scott R.
    Curtis, Christine A.
    Balog, Anna
    Kaplan, David
    Lazarus, Hillard M.
    BLOOD, 2010, 116 (21) : 555 - 555
  • [7] Pegfilgrastim compared with filgrastim after high-dose melphalan and autologous hematopoietic peripheral blood stem cell transplantation in multiple myeloma patients
    Martino, Massimo
    Pratio, Giulia
    Messina, Giuseppe
    Irrera, Giuseppe
    Massara, Elisabetta
    Messina, Giuseppe
    Console, Giuseppe
    Iacopino, Pasquale
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2006, 77 (05) : 410 - 415
  • [8] Tandem autologous hematopoietic cell transplantation with sequential use of total marrow irradiation and high-dose melphalan in multiple myeloma
    Sebastian Giebel
    Małgorzata Sobczyk-Kruszelnicka
    Sławomir Blamek
    Maria Saduś-Wojciechowska
    Jacek Najda
    Tomasz Czerw
    Włodzimierz Mendrek
    Grzegorz Woźniak
    Bożena Jochymek
    Michał Radwan
    Wojciech Leszczyński
    Łukasz Dolla
    Andrea D’Amico
    Krzysztof Ślosarek
    Jerzy Hołowiecki
    Leszek Miszczyk
    Bone Marrow Transplantation, 2021, 56 : 1297 - 1304
  • [9] The Result of a Phase 1 Study of Selinexor in Combination with High-Dose Melphalan and Autologous Hematopoietic Cell Transplantation for Multiple Myeloma
    Nishihori, Taiga
    Alsina, Melissa
    Ochoa, Jose
    Puglianini, Omar Alexis Castaneda
    Baz, Rachid
    Shain, Kenneth H.
    Brayer, Jason B.
    Kim, Jongphil
    Dumala, Michael
    Turner, Joel G.
    Sullivan, Daniel M.
    BLOOD, 2019, 134
  • [10] Arsenic trioxide with ascorbic acid and high-dose melphalan for autologous hematopoietic stem cell transplantation for multiple myeloma.
    Qazilbash, Muzaffar H.
    Saliba, Rima M.
    Davis, Marilyn S.
    Mendoza, Floralyn L.
    Hosing, Chitra
    Couriel, Daniel R.
    De Lima, Marcos
    Kebriaei, Partow
    Weber, Donna M.
    Wang, Michael
    Alousi, Arnin M.
    Matthes, Steven G.
    Jones, Roy B.
    Champlin, Richard E.
    Giralt, Sergio A.
    BLOOD, 2006, 108 (11) : 881A - 881A
12345